- One-year antibody persistence and safety of a 4-dose schedule of MenACWY-CRM in healthy infants from South Korea
-
Lee HJ, Jo DS, Kim YK, Lee H, Kim KH, Lee D, Curina C, Costantini M, Barbi S, Miao Y, Pellegrini M
- KMID: 2455080
- Clin Exp Vaccine Res.
- 2019 Jul;8(2):94-102.
- doi: 10.7774/cevr.2019.8.2.94
PURPOSE: Results from a post-marketing study to generate evidence on 1-year antibody persistence and safety following vaccination of infants from South Korea with the quadrivalent meningococcal conjugate vaccine MenACWY-CRM. MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
